GlassScriptPhysician profile
Miles Sanderson
NPI 1134758790
$5,497.76
in general payments reported to CMS, 2019-2025
11 companies · $3,356 in 2025
The $3,356 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,141 · 2025: $3,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,450 · Travel and Lodging: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,449.90 |
| Travel and Lodging | $1,047.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,714.44 | 2024-2025 | Eterna, Proclaim, Octrode |
| Si-Bone, INC. | $842.71 | 2025 | |
| Globus Medical, INC. | $834.57 | 2025 | Senza, Omnia, Nevro |
| Nevro Corp. | $609.58 | 2024 | Senza |
| Medtronic, INC. | $204.44 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $117.25 | 2025 | Wavewriter Alpha Prime 16, Intracept |
| Spr Therapeutics, INC | $64.81 | 2025 | Sprint Pns System |
| Averitas Pharma INC. | $33.62 | 2024 | Qutenza |
| Mindray Ds USA, INC. | $30.80 | 2024 | Te7 Max, Te X |
| Saluda Medical Americas, INC. | $28.74 | 2025 | Evoke |
| Stryker Corporation | $16.80 | 2025 | Omnicurve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miles Sanderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.